Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

bohemianclubman 78 posts  |  Last Activity: 10 hours ago Member since: May 19, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Terry - Dr.Olivier

    by biowatchdog Apr 14, 2016 11:49 PM
    bohemianclubman bohemianclubman Apr 15, 2016 10:50 AM Flag

    Let's be fair rocks, anybody that can buy their way into a short position is capable of things that are impossible for others.

  • Reply to

    The Terry Freak Show Never Ends

    by jad9000 Apr 14, 2016 2:36 PM
    bohemianclubman bohemianclubman Apr 14, 2016 3:23 PM Flag

    Every post that I put up ever anymore disappears, even if it has nothing to do with terese being crazy, which is frustrating because I enjoy this board minus her. The problem is that in my honest and very humble opinion, she never ever leaves her computer, or this board. Not even when she is on the toilet.... OK so maybe this post should get deleted

  • Reply to

    New post on NTMIR

    by checksurshorts Apr 13, 2016 9:43 AM
    bohemianclubman bohemianclubman Apr 13, 2016 10:24 AM Flag

    Thanks Checks

  • bohemianclubman bohemianclubman Apr 11, 2016 12:19 PM Flag

    When Insmed purchased arikayce in 2010 the NTM numbers were really low but have been going up with better diagnoses as well as new cases. NTM Info and News claims 15000 to 18000 new cases each year.

    It is barely ever mentioned, but arikayce also has completed a successful phase II trial and received orphan designation for non CF Bronchiectasis. It has been mentioned several times on this board that Aradigm, a company with a total market cap of less than 70 million has a phase III trial planned for this disease whose numbers are increasing nearly as quickly as are the NTM numbers. The numbers for non CF Bronciectasis are huge and I find it difficult to believe that Insmed management doesn't have a plan to make LOI available for this NTM cousin.

    As is always the case, there is likely much more discussion within the walls of Insmed than is obviously known to the market. Reading some of the possibilities, whether likely or even possible, has always been an attraction of message boards. Those that bring up anything other than recalcitrant NTM patients on this board are immediately labeled as liars.

    Yesterday Tom Watson played in his last Masters, and when interviewed talked about always leaving an egg salad sandwich on the bench at number 13 in honor of his caddie, lost years ago to ALS. So I will say it: An iPLEX to combat ALS trial will be started by the end of this decade.

  • Reply to

    2018 is getting closer.....

    by insmhistorian Mar 31, 2016 3:02 PM
    bohemianclubman bohemianclubman Apr 1, 2016 1:27 PM Flag

    No H I don't think it is possible to read to much into board appointees. Many don't find boards to be anything more than an honorary title, and then Carl Icahn will spend a billion dollars to get a company he has a stake in to bring on new board members. When I saw that Myrtle Potter was named to the board two things quickly came to mind. 1. Her name sounds like a tv character, and 2. Many of the drugs she oversaw at Genentech - Herceptin, Avastin, Xolair..... were all licensed and not developed by Genentech. Interesting in light of the iPLEX talk

  • Reply to

    2018 is getting closer.....

    by insmhistorian Mar 31, 2016 3:02 PM
    bohemianclubman bohemianclubman Apr 1, 2016 12:37 PM Flag

    Hi H, in my opinion much of the future of iPLEX will be determined by the result of the Shire trial. No winkieterryobsessivenutjob will convince me that if iPLEX works to prevent blindness in preemies that one of the big pharmas won't want to trial the drug for something else, although I do agree with Zake that Insmed will likely license the drug to a bigger player, at least until Insmed becomes a big player.

  • Reply to

    Things that make you go hmm .....

    by arikaycerocks Apr 1, 2016 10:40 AM
    bohemianclubman bohemianclubman Apr 1, 2016 12:32 PM Flag

    lol, I guess that you are right rocks, and I won't get any more suggestions since the post was deleted..... I thought, maybe if I go right to the top, so I called Yahoo and asked for Marissa Mayer and can you believe that they wouldn't put me through to her? Oh well, I guess I'm pretty lucky if my biggest concern is trying to make the Yahoo INSM message board more "user friendly."

  • Reply to

    Things that make you go hmm .....

    by arikaycerocks Apr 1, 2016 10:40 AM
    bohemianclubman bohemianclubman Apr 1, 2016 11:11 AM Flag

    Well, in my opinion it has gotten completely out of hand. Yesterday evening Zake and Historian had a little iPLEX discussion going, and then terry/winkie had something like 50 straight posts to totally bury their discussion. While I'm sure nothing can be done, and I shouldn't even care, for some reason I have to try.... any suggestions? I'm willing to spend a whole day making calls and sending e-mails, which is nothing compared to the obsession of spending almost every waking hour here....

  • Reply to

    New NTMir Posts

    by checksurshorts Nov 27, 2015 12:05 PM
    bohemianclubman bohemianclubman Apr 1, 2016 9:59 AM Flag

    Thanks Checks! We have finally reached the quarter when Insmed and it's shareholders should find out if the company has an approved drug to sell, then hopefully we will see many stories like the one you posted!

  • Reply to

    2018 is getting closer.....

    by insmhistorian Mar 31, 2016 3:02 PM
    bohemianclubman bohemianclubman Mar 31, 2016 3:49 PM Flag

    lol H, did I sense a certain degree of.... taunting in your post??

  • bohemianclubman by bohemianclubman Mar 31, 2016 9:54 AM Flag

    Several that post here, like myself, have been members of Investors Village for years. Zake, Historian, Checks and others can attest to the fact that on that board we see not just the posters, but also the visitors to the site. The visitors dwarf the number of actual posters. If we can assume that this board also gets visitors with no intention to post, then we know that what they find is an obsessive compulsive moronic multi-id personality that spends every minute of every day here trying to bury anything other posters try to say. It's sad, and it probably doesn't hurt the share price, but it destroys the potential of this message board to be any sort of tool for retail investors. Yahoo, who's share price minus their Ali Baba stake is close to zero, should try to protect the one area - message boards, that they still remain a leader....

  • Reply to

    Why approve Arikayce for more than NTM ?

    by arikaycerocks Mar 30, 2016 12:09 PM
    bohemianclubman bohemianclubman Mar 30, 2016 3:52 PM Flag

    Citing your sources to back up your statements earned you a quick 6 thumbs down.... that has to be from someone that never cites sources to back statements, don't you think?

  • bohemianclubman bohemianclubman Mar 30, 2016 1:50 PM Flag

    Holy macaroni!!! Not even little girls repeat themselves as often as you do!!!!!!

  • Reply to

    Why did the EMA block a breakthrough therapy?

    by arikaycerocks Mar 25, 2016 5:51 PM
    bohemianclubman bohemianclubman Mar 30, 2016 11:14 AM Flag

    rehdvm, you may be a breath of fresh air compared to bizarro girl, but nothing has changed.... you post a bunch of "words" that make you sound smart, but nobody really understands, You let us all know that apparently you picked the exact right day to sell all your shares in 2014. A few years ago you were posting on and on about master files and how they could help the Insmed cause, and then on a quarterly conference call you asked Lewis (maybe it was Sharoky) about starting one of your master files..... and he didn't have a half a clue about what you were talking about. We know that you are a veterinarian, and likely know more about medicine than we do, but your arrogance hasn't waned at all

  • Reply to

    Terry - where did you buy INSM short shares?

    by arikaycerocks Mar 18, 2016 7:41 PM
    bohemianclubman bohemianclubman Mar 28, 2016 10:52 AM Flag

    Tom, the key word regarding the aricaycerocks post regarding "buying short shares" is sarcasm. He was being sarcastic towards a poster who at times lets us all know that he is both long and short.....

  • Reply to

    Rook - please do us all a favour ...

    by arikaycerocks Mar 23, 2016 12:49 PM
    bohemianclubman bohemianclubman Mar 23, 2016 3:44 PM Flag

    LOL, shame on me! At least he stays true to form and now lets us know that he shorted at 12.92 at the close yesterday. I wonder if he sold his long position before going short, or if he is long and short? He may even be short and long....

  • Reply to

    Rook - please do us all a favour ...

    by arikaycerocks Mar 23, 2016 12:49 PM
    bohemianclubman bohemianclubman Mar 23, 2016 1:14 PM Flag

    I've been told to just block his posts and ignore him, but his many ID's make that impossible to do. Then, once again over the weekend he was using my cloned user name and posting just outright freaky stuff about the GLBT club, etc. etc. That said, since I can't block him and he can't refrain from posting under the cloned bohemainclubman ID, I will simply make fun of him. Everything you say about him Rocks is true, and it would take a whole team of shrinks from Vienna to even come close to deciphering how one can spend their entire life on one stock message board. Yesterday he claimed to be long 17000 shares, and if he would copy and paste that from his brokerage positions I would likely drop from heart failure, but surely we will here by days end that he exited that position this a.m. at 13....

  • Reply to

    A little OT.....but not completely

    by insmhistorian Mar 17, 2016 12:16 PM
    bohemianclubman bohemianclubman Mar 17, 2016 1:10 PM Flag

    H, Shire now has a 30 billion dollar market cap and their ROP trial ends in April.... which is pretty soon. I believe that they had some conversations with some of the top child ophthamologists on the planet that were employed by Premacure before buying the company. No matter how much iPLEX is swept under the rug, successful trial data is going to once again make iPLEX a topic of conversation. It has now been 8 years since Cephalons' failed ALS trial using IGF1. ALS remains one of the Holy Grails of medicine and I will not be convinced that the future does not continue to hold an IGF1BP3 ALS trial using a delivery method other than sub cutaneous. Shire is using continuous IV delivery.

    I started following Insmed in 2009 after one of my best friends from high school, and star of the tennis team developed ALS. Watching his decline has been gut wrenching, and I have never totally lost faith that one day some company will find something to help alleviate the misery of ALS. Will it be iPLEX? After all of these years iPLEX still remains near the top of the list of potential weapons against ALS. If Shire is successful helping likely blind babies see, iPLEX will be back at the top of the list.. This is sort of personal for me, and when blabber boy tells us for the 15000th time that iPLEX is dead.... please excuse me for my reply to him....

  • Reply to

    Does anyone here really know

    by bohemianclubman Mar 16, 2016 10:04 AM
    bohemianclubman bohemianclubman Mar 16, 2016 10:56 AM Flag

    Lol H, If Lewis really did say that it would have been posted here about a dozen times since I asked the question! I'm not even sure if that would be proper use of language? There are historical landmarks. Historical buildings. Historical people. Historical drugs? I don't think so.

  • bohemianclubman by bohemianclubman Mar 16, 2016 10:04 AM Flag

    If Lewis ever really called iPLEX "an historic drug" ? Someone keeps posting that he said that, and this poster does use the quotation marks, but I can't find those words coming from Mr. Lewis's mouth. Seeing that Shire is moving ever closer with ROP does have my mind wandering to iPLEX a bit. Thanks.

INSM
11.96+0.15(+1.27%)May 25 4:00 PMEDT